Carcinogenesis, Teratogenesis & Mutagenesis ›› 2006, Vol. 18 ›› Issue (6): 447-449.doi: 10.3969/j.issn.1004-616x.2006.06.009

Previous Articles     Next Articles

Correlation Between Expressions of Survivin and P53 Proteins and Relapse of Transi-tional Cell Carcinoma of Bladder

CHEN Wen, ZHENG Shan, XIAO Ze-jun, LIU Xiu-yun, DI Xue-bing, XU Nin-zhi, FANG Jian, CHENG Shu-jun, GAO Yan-ning   

  1. (1.Cancer Institute (Hospital),2.Department of pathology;3.Department of urinary surgery;4.Lab of molecular cell biology, Peking Union Medical College & Chinese Academy of Medical Science, Beijing 100021, China)
  • Received:2005-12-06 Revised:2006-06-02 Online:2006-11-30 Published:2006-11-30
  • Contact: GAO Yan-ning

Abstract: 【ABSTRACT】 BACKGROUND & AIM: To explore the correlation between up-regulated expressions of Survivin and P53 proteins in the tumor tissues and relapse of transitional cell carcinoma (TCC) of the bladder. MATERIALS AND METHODS: Survivin and P53 proteins in the paraffin-embedded tumor tissues derived from 75 cases of TCC were examined by immunohistochemical staining. The expressions of the two proteins and the pathological grading were assessed, using Mantel-Haenszel analysis to calculate the odds ratios and significance level for difference of the indicators between the relapse and non-relapse groups of the TCC patients. RESULTS: The positive staining rates of Survivin in cytoplasm, Survivin in nuclei, P53, and cytoplasmic Survivin plus P53 were 76.0%, 30.67%, 53.33% and 84.0%, respectively. The sensitivity for predicting the relapse were 87.50%, 37.50%, 71.88% and 96.88%, respectively. The specificities were 32.56%, 74.42%, 61.90% and 25.58%, respectively. The relative risks for the relapse were as following, Survivin (cytoplasm): OR=3.38, 95%CI (0.99-11.52), P=0.044; P53: OR=3.91, 95%CI (1.46-10.45), P=0.005; Survivin plus P53: OR=10.66, P=0.0087. The odds ratios by pathological grading classification were, P53: OR=3.41, P=0.016; P53 plus Survivin: OR=8.86, P=0.022. CONCLUSION: Over-expression of P53 protein in the tumor tissues might suggest a high risk for recurrence of bladder TCC, whereas the association between overexpression of Survivin and relapse of TCC was not demonstrated.

Key words: survivin, P53, bladder cancer, transitional cell carcinoma, relapse

CLC Number: